Early Detection of Prostate Cancer of Syrian Men
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: PSA, DRE.
- Who it may be relevant to
- Registry conditions: the Detection of Prostate Cancer in Men. Basic parameters: 40 years — 65 years · Male.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Syria
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Early Detection of Prostate Cancer Among Men in the Middle Region of Syria
Overview
Prostate cancer is a significant health concern in the Middle East, including Syria, where many cases are diagnosed at advanced stages due to low awareness and inadequate screening practices. The mortality-to-incidence ratio for prostate cancer in the region is alarmingly high, indicating a pressing need for effective early detection strategies.
Detailed description
This study aims to assess the awareness, attitudes, and practices regarding prostate cancer screening among men in the middle region of Syria, with the goal of identifying barriers to early detection and informing public health interventions.
Interventions
- Diagnostic test PSA
Prostate-Specific Antigen test, a blood test used to measure the level of PSA in a man's blood. PSA is a protein produced by the prostate gland, and elevated levels can indicate various conditions, including prostate cancer, benign prostatic hyperplasia (BPH), or prostatitis. - Diagnostic test DRE
A digital rectal exam (DRE) is a procedure where a doctor inserts a lubricated, gloved finger into the rectum to check for abnormalities.
Primary outcome measures
- Number of ptients with early signs of prostate cancer [Time frame: From Participant enrolment to the end of the study at 2 weeks]
Eligibility criteria
Inclusion criteria
- Men aged 40 years and older residing in the middle region of Syria.
Exclusion criteria
- Men with a previous diagnosis of prostate cancer.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
Syria · 1 center
- Al-Hawash Private University — Homs
Identifiers
NCT: NCT07075666 · 02-05-2025